Charles Russell Speechlys advises Kreos Capital V (UK) Limited on senior secured loan to Pharming Group NV
Charles Russell Speechlys LLP advised Kreos Capital V (UK) Limited (“Kreos”) on its €21 million senior secured loan to Pharming Group NV (“Pharming”) and its subscription for €6 million subordinated redeemable convertible bond issued by Pharming.
The transaction is part of a larger fundraising exercise carried out by Pharming to raise €104 million before costs (comprising of straight debt, convertible bonds and proceeds of rights issue) to, amongst others, acquire all commercialisation rights to its own product RUCONEST® in North America and to repay its existing debt facility.
The Charles Russell Speechlys core team comprised Corporate Partner Chris Putt, Corporate Associates Rossana Conti and Amelly Kok and Banking Partner Daniel Sullivan.
News & Insights
Focus Antitrust - 21 October 2020
The latest edition of our regular Focus Antitrust update.
Charles Russell Speechlys advises Fit Cloud Technology Ltd on Maven investment
Membr’s innovative fitness platform connects the fitness industry with its members.
Charles Russell Speechlys advises on sale of dental practice Feltham Dental
Feltham Dental was established in 1982, the business is an integral part of the community and has many generations of loyal patients.